Cargando…
Hepatic Amyloidosis With Multiorgan Involvement
Amyloidosis is a diverse entity that poses both diagnostic and treatment challenges. Whether systemic or local, amyloidosis has varied manifestations including occasional hepatic involvement. Hepatic amyloidosis, although rare, should be on the differential for those with unexplained hepatomegaly, c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115552/ https://www.ncbi.nlm.nih.gov/pubmed/37091204 http://dx.doi.org/10.14309/crj.0000000000000999 |
_version_ | 1785028234473111552 |
---|---|
author | Duve, Robert J. Moga, Tiberiu G. Yang, Kevin Mahl, Thomas C. Dove, Eric |
author_facet | Duve, Robert J. Moga, Tiberiu G. Yang, Kevin Mahl, Thomas C. Dove, Eric |
author_sort | Duve, Robert J. |
collection | PubMed |
description | Amyloidosis is a diverse entity that poses both diagnostic and treatment challenges. Whether systemic or local, amyloidosis has varied manifestations including occasional hepatic involvement. Hepatic amyloidosis, although rare, should be on the differential for those with unexplained hepatomegaly, cholestasis, alkaline phosphatase elevations, other associated organomegaly, and those with certain epidemiologic risks. In this study, we report a case of a man with systemic amyloid light chain amyloidosis with multiorgan involvement, acute liver injury, cholestasis, nephrotic syndrome, cardiomegaly, and bleeding diathesis. |
format | Online Article Text |
id | pubmed-10115552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-101155522023-04-20 Hepatic Amyloidosis With Multiorgan Involvement Duve, Robert J. Moga, Tiberiu G. Yang, Kevin Mahl, Thomas C. Dove, Eric ACG Case Rep J Case Report Amyloidosis is a diverse entity that poses both diagnostic and treatment challenges. Whether systemic or local, amyloidosis has varied manifestations including occasional hepatic involvement. Hepatic amyloidosis, although rare, should be on the differential for those with unexplained hepatomegaly, cholestasis, alkaline phosphatase elevations, other associated organomegaly, and those with certain epidemiologic risks. In this study, we report a case of a man with systemic amyloid light chain amyloidosis with multiorgan involvement, acute liver injury, cholestasis, nephrotic syndrome, cardiomegaly, and bleeding diathesis. Wolters Kluwer 2023-04-19 /pmc/articles/PMC10115552/ /pubmed/37091204 http://dx.doi.org/10.14309/crj.0000000000000999 Text en © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Duve, Robert J. Moga, Tiberiu G. Yang, Kevin Mahl, Thomas C. Dove, Eric Hepatic Amyloidosis With Multiorgan Involvement |
title | Hepatic Amyloidosis With Multiorgan Involvement |
title_full | Hepatic Amyloidosis With Multiorgan Involvement |
title_fullStr | Hepatic Amyloidosis With Multiorgan Involvement |
title_full_unstemmed | Hepatic Amyloidosis With Multiorgan Involvement |
title_short | Hepatic Amyloidosis With Multiorgan Involvement |
title_sort | hepatic amyloidosis with multiorgan involvement |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115552/ https://www.ncbi.nlm.nih.gov/pubmed/37091204 http://dx.doi.org/10.14309/crj.0000000000000999 |
work_keys_str_mv | AT duverobertj hepaticamyloidosiswithmultiorganinvolvement AT mogatiberiug hepaticamyloidosiswithmultiorganinvolvement AT yangkevin hepaticamyloidosiswithmultiorganinvolvement AT mahlthomasc hepaticamyloidosiswithmultiorganinvolvement AT doveeric hepaticamyloidosiswithmultiorganinvolvement |